InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-32.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Wahlstrom Mats, Director. Insider active across 3 companies, notably TriSalus Life Sciences, Inc.. Cumulatively, 9 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €30k. History available since 25 February 2022. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
30,000 shares0Common StockSEC:0001610717-26-000201:0
37,602 shares0Common StockSEC:0001628280-26-035667
37,602 shares0Common StockSEC:0001628280-26-035667:0
25,188 shares@ US$3.9776.2% of flowCommon StockSEC:0001415889-24-029907:0
5,000 shares@ US$4.5517.4% of flowCommon StockSEC:0001415889-24-027656:0
Ideal exit: 19 Aug 2025 (T+270)
2,040 shares@ US$4.166.4% of flowCommon StockSEC:0001415889-24-027587:0
Ideal exit: 17 Aug 2025 (T+270)
99,988 shares0Common StockSEC:0001610717-24-000060:0
14,997 shares@ US$1.66718.2% of flowCommon StockSEC:0001610717-24-000044:0
10,006 shares@ US$11.63630.060% mcap100.0% of flowCommon StockSEC:0001567619-22-005922:0
9 of 9 declarations
About Wahlstrom Mats
Mats Wahlstrom is a Director at TriSalus Life Sciences, Inc. and Coherus BioSciences, Inc. He brings his expertise in corporate governance and strategy, contributing to guiding the board's decisions.
